Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of aldosterone blockade on chronic allograft nephropathy after kidney transplantation
2011-002518-35Phase 2Terminated
- Sponsor
- Karl Emil Kristensen
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eplerenone in Chronic Allograft Kidney Disease (CKaD), sponsored by Karl Emil Kristensen. Started Feb 2012; status: terminated.
02
Drugs
eplerenone
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on 2011-002518-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002518-35.